Atenolol/Nifedipine

阿替洛尔/硝苯地平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtenolol/Nifedipine
Drug Alias NameNifedipine/Atenolol硝苯地平和阿替洛尔硝苯地平•阿替洛尔Nifedipine•AtenololAtenolol and Nifedipine +[11
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAdrenergic receptors
Therapy Area/IndicationsHypertensionAngina Pectoris
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date1986/01/01
Country/TerritoryItalyGermanyFrance
CombinationsYes AtenololNifedipine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertensionAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC08CA55
Related LinksN/A